Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?

Gut Liver. 2023 Sep 15;17(5):668-669. doi: 10.5009/gnl230338.NO ABSTRACTPMID:37712188 | PMC:PMC10502489 | DOI:10.5009/gnl230338

Source: Gut and Liver - September 15, 2023 Category: Gastroenterology Authors: Hyun Ho Choi Source Type: research